Nicotine Regulatory Consultancy
Guiding Tobacco Manufacturers Through the Regulatory Challenges to Market
The FDA and other regulators are paying close attention to the nicotine industry, which means manufacturers need to understand the impact of their product and be able to demonstrate harm mitigation.
Where McKinney RSA Comes In
Our collective of toxicologists, chemists, behavioral scientists, and research professionals, with a cumulative experience exceeding two centuries deeply engaged in nicotine regulation, is primed to swiftly comprehend the nuances of your business hurdles and design bespoke studies that align with your financial constraints.
Using history as our guide, McKinney RSA’s consortium of experts balances your needs with the regulatory environment. We quickly establish trust with your team so that we can:
- Find the right mix between product innovation and harm reduction
- Create custom studies that live at the intersection of best practice and your business maturity
- Efficiently navigate regulatory submission processes
- Maintain compliance and help you leverage your data to influence the industry
- Help build your expertise within the nicotine industry
Our Nicotine Services Include:
Getting a nicotine product to market, and staying in regulatory compliance, is no small feat. Got questions on the process? We’ve got answers.
3 min. read
On August 22, 2023 our very own Dr Willie McKinney, CEO, had the opportunity to express his views and opinions […] Read More
14 min. read
For patients who can’t quit smoking there are several reduced-harm alternatives. None of these alternative nicotine products are safe. They […] Read More
4 min. read
It’s no secret that the FDA’s requirements for investigational tobacco product (ITP) applications can be confusing. But what if you […] Read More
"*" indicates required fields